Meta-analysis In addition, a meta-analysis of these trials found that semaglutide reduced HbA1c by an average of 1.3% and helped participants lose between 5% to 15% of their body weight, showing its effectiveness in both weight management and blood sugar regulation
In particular, the physiological role of LEAP2 beyond GHSR antagonism, the tissue-specific actions of ghrelin and desacyl-ghrelin, and the functional relevance of the ghrelin/LEAP2 ratio across different metabolic states require further clarification
Average loss: ~1012 lb over 52 weeks on the 3 mg and 4.5 mg doses (AWARD-11)
A provider should review these alongside oxidative stress markers to determine whether antioxidant support is clinically justified for your specific metabolic profile
Accessed on November 6, 2025 at Reis, G., & Kosmas, C